Investing Profile

Andrew Bayliffe

InvestorVC
Venture Partner at Apple Tree Partners
appletreepartners.com/teamLondon
Photo of Andrew Bayliffe, ATP (Apple Tree Partners)
Your Intro Paths to Andrew Bayliffe

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Andrew Bayliffe on

cb
Current Investing Position
ATP (Apple Tree Partners)
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M

Andrew Bayliffe is on these Sector & Stage Rankings

Andrew Bayliffe's Experience

Chief Scientific Officer Marengo Therapeutics2020 - Present
Venture Partner Apple Tree Partners2019 - Present
Head, Respiratory and Inflammation Research Unit GSK2015 - 2020
Global Development Leader - Respiratory & Inflammation GSK2013 - 2015
Head, Translational Medicine - Biopharmaceuticals Innovation Unit GSK2011 - 2013
Clinical Pharmacology Leader - Biopharmaceuticals R&D GSK2008 - 2011
Clinical Pharmacology Leader - Immunology & Inflammation R&D GSK2004 - 2008
Translational Scientist - Clinical Pharmacology & Experimental Medicine GSK2002 - 2004
Research Scientist, Pharmacogenetics & Applied Diagnostics GSK2000 - 2002
Research Scientist AstraZeneca1998 - 2000

Andrew Bayliffe's Education

University of Leeds Doctor of Philosophy - PhD Pharmacology and Molecular Biology
The Manchester Metropolitan University Bachelor of Science - BS Pharmacology